Tubulis

Tubulis® generates uniquely matched protein-drug conjugates by combining proprietary new technologies with disease-specific biology. Their goal is to expand the therapeutic potential of antibody-drug conjugates (ADCs), usher in a new era, and deliver better outcomes for patients. They will leverage their discovery capabilities and address development challenges through partnerships targeting antibodies and chemical assets, advancing a range of conjugates, including indicators.